Production (Stage)
Sana Biotechnology, Inc.
SANA
$2.17
-$0.10-4.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.38% | 5.82% | -10.97% | 32.29% | 3.61% |
| Total Depreciation and Amortization | -9.09% | -11.65% | -8.81% | -3.62% | 3.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -127.97% | 551.95% | 355.27% | -138.31% | 146.30% |
| Change in Net Operating Assets | -120.87% | -106.37% | 72.29% | 6.54% | 22,771.88% |
| Cash from Operations | 14.07% | 12.00% | 17.91% | 14.07% | 17.72% |
| Capital Expenditure | 47.42% | -66.88% | -344.28% | -255.61% | -117.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.80% | -73.50% | -87.21% | -83.04% | -76.20% |
| Cash from Investing | 247.14% | -89.85% | -105.84% | -102.11% | -87.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.91% | 506.73% | 522.88% | 490.02% | 4,743.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -93.42% | 531.20% | 548.05% | 513.54% | 4,743.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -911.93% | 88.08% | -2,538.57% | -118.02% | 137.62% |